Antimicrobial Resistance

Gain valuable insights into the pressing challenge of diagnosing gastrointestinal infections (GI) in the context of antimicrobial resistance (AMR)

With the landscape of healthcare rapidly evolving, diagnostic innovation, health equity, and the strategic value of laboratory services are emerging as critical focal points.

Antimicrobial resistance in Pseudomonas aeruginosa remains a serious health threat because multiple mechanisms may be involved that further complicate the management of infections.

Surgical-site infection (SSI) is one of the most common healthcare-associated infections (HAI) globally, and the most frequent postoperative complication

In recognition of World AMR Awareness Week (WAAW), this Viewpoints Series interview with pharmacist Jacob Morton explores the critical issue of limited public awareness about antimicrobial resistance (AMR) and its impact on patient healthcare.

Discover stories that highlight the realities faced by individuals battling superbugs and the vital role medical professionals play.

Explore 5 lessons from an AMS Pharmacist

Explore strategies for managing sepsis and AMR concurrently.

In this MLO feature article, Chris Groke, Senior Medical Science Liaison at bioMérieux, breaks down the history of diagnostic innovation in the fight against antimicrobial resistance (AMR). As a Board-Certified Infectious Diseases Pharmacist, Groke shares knowledge and insight into the evolution of AMR and the critical role diagnostics play in addressing this global public health threat.

Play MICROBE LEAP, bioMérieux’s interactive AMS game, to test your diagnostic knowledge and antimicrobial stewardship skills as a Patient Protector or Resistance Avenger!

Fifty-two medical specialty organizations and associations from across India are taking on antimicrobial resistance (AMR), paving the way for low- to middle-income countries looking to mitigate the impact of AMR. The country recognizes the severe impact caused by neglecting AMR, with over a million deaths attributed to AMR-related complications each year.

The antimicrobial stewardship (AMS) landscape is rapidly changing and diagnostics are revolutionizing how medical professionals meet AMS goals. In this CIDRAP ASP webinar and roundtable, experts discuss insights and share personal experiences regarding diagnostic trends and emerging opportunities for AMS.

A retrospective analysis of 382,149 Staphylococcus aureus isolates from U.S. Veterans Health Administration outpatients reveals significant shifts in antimicrobial resistance patterns over a 10-year period.

This groundbreaking study by Fernando and McKibbin employs sophisticated macroeconomic modeling to assess the global economic impacts of antimicrobial resistance (AMR) across G20 countries

As part of a CIDRAP three-part webinar series, bioMérieux is proud to support this second installment that explores the shifting landscape of the rapid diagnostic laboratory, highlighting the transformative impact brought about by new technologies.

Results from the Society of Critical Care Medicine Discovery VIRUS international COVID-19 Registry aim to determine the rate and factors associated with early empiric antibiotic (EEAB) treatment to help set goals for antimicrobial stewardship efforts, in the post-pandemic era.

According to predictions from professor and practicing intensivist, Dr. Hannah Wunsch, war, multidrug resistance, climate change, emerging diseases, and reduced confidence in vaccination will be among the factors that influence an expected increase in infectious diseases in the ICU.

Global antimicrobial resistance (AMR) — the “silent pandemic” — is already causing a significant burden on healthcare systems, with COVID-19 only adding to the complexity and challenge of this global public health threat.

In this article, Brian Raux, PharmD, discusses the global impact COVID-19 has had on the rise of antimicrobial resistance (AMR) and the alarming increase of hospital-acquired infections (HAI). 

The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota interviewed Christian Lillis, founder of the Peggy Lillis Foundation, about the fight against Clostridioides difficile through education, awareness, and reducing unnecessary antibiotic use.

A group of global experts from Italy, Lebanon, Thailand, India, the U.S., Colombia and China speak about the need for rapid diagnostic tests and efficient laboratory workflows for multi-drug resistant (MDR) Gram-negative infections.

Researchers around the world worked together to identify educational gaps and systemic barriers obstructing adherence to antimicrobial stewardship (AMS) principles in France, India, Mexico, and the United States.

bioMérieux pharmacist Tristan Timbrook and team analyzed data from the BIOFIRE® Pneumonia (PN) and BIOFIRE® Blood Culture Identification 2 (BCID2) Panels using BioFire Syndromic Trends, a cloud-based surveillance network software, to determine the prevalence of multi-drug resistant organisms (MDRO) across various US region

In their proof-of-concept study, Dr. Claeys and colleagues compared three rapid diagnostic test panels using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy, or DOOR MAT, to diagnose Gram-negative bloodstream infections.

ECCMID has become one of the most comprehensive and influential congresses in the field of microbiology and infectious diseases, bringing together more than 14,000 colleagues from all over the world. 

In this webinar, Dr. Joel Mortensen, Director of the Diagnostic Infectious Diseases Testing Laboratory at Cincinnati Children's Hospital, will explore the positive impact and untapped potential from using the BACT/ALERT® VIRTUO® blood culture system.